AR091679A1 - POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER - Google Patents

POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER

Info

Publication number
AR091679A1
AR091679A1 ARP130102397A AR091679A1 AR 091679 A1 AR091679 A1 AR 091679A1 AR P130102397 A ARP130102397 A AR P130102397A AR 091679 A1 AR091679 A1 AR 091679A1
Authority
AR
Argentina
Prior art keywords
acetilcoline
nicotinic
receiver
positive allosteric
modular
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/063219 external-priority patent/WO2013007621A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR091679A1 publication Critical patent/AR091679A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Un compuesto de acuerdo con la fórmula (1) en donde R¹, R², R³, R⁴ y R⁵ son H; R⁶ se selecciona de metilo e hidroximetilo; A⁷ es C-R⁷, A⁸ es N y A⁹ es C-R⁹; R⁷, R¹⁰ y R¹¹ son H; R⁹ es OR¹², en donde R¹² representa un resto de anillo saturado monocíclico que tiene 4 - 6 átomos de anillo, en donde uno de dichos átomos de anillo es O y el resto es C; y sales farmacéuticamente aceptables de los mismos.Claim 1: A compound according to formula (1) wherein R¹, R², R³, R⁴ and R⁵ are H; R⁶ is selected from methyl and hydroxymethyl; A⁷ is C-R⁷, A⁸ is N and A⁹ is C-R⁹; R⁷, R¹⁰ and R¹¹ are H; R⁹ is OR¹², where R¹² represents a monocyclic saturated ring moiety having 4-6 ring atoms, wherein one of said ring atoms is O and the rest is C; and pharmaceutically acceptable salts thereof.

ARP130102397 2012-07-06 2013-07-05 POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER AR091679A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/063219 WO2013007621A1 (en) 2011-07-08 2012-07-06 Positive allosteric modulators of nicotinic acetylcholine receptor

Publications (1)

Publication Number Publication Date
AR091679A1 true AR091679A1 (en) 2015-02-18

Family

ID=48745970

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP130102397 AR091679A1 (en) 2012-07-06 2013-07-05 POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER
ARP130102396 AR091678A1 (en) 2012-07-06 2013-07-05 POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP130102396 AR091678A1 (en) 2012-07-06 2013-07-05 POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER

Country Status (2)

Country Link
AR (2) AR091679A1 (en)
WO (2) WO2014006120A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018011453A (en) 2016-03-22 2019-01-10 Merck Sharp & Dohme Allosteric modulators of nicotinic acetylcholine receptors.
CA3098583C (en) 2018-05-01 2023-05-16 Merck Sharp & Dohme Corp. Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008307195B2 (en) 2007-10-04 2012-11-22 F. Hoffmann-La Roche Ag Cyclopropyl aryl amide derivatives and uses thereof
CA2761639C (en) 2009-05-29 2016-06-07 Raqualia Pharma Inc. Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
US8497271B2 (en) * 2009-10-07 2013-07-30 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88
UA111746C2 (en) 2011-07-08 2016-06-10 Х. Луннбек А/С POSITIVE Allosteric Modulators of the Nicotinic Acetylcholine Receptor

Also Published As

Publication number Publication date
AR091678A1 (en) 2015-02-18
WO2014006117A1 (en) 2014-01-09
WO2014006120A1 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
AR102177A1 (en) HETEROARILO COMPOUNDS AS BTK INHIBITORS AND USES OF THE SAME
CR20160291A (en) CORTISTATINE AND SYNTHESIS ANALOGS AND USES OF THE SAME
EA201591486A1 (en) THE IOMIDAZOPYRIDINE COMPOUNDS
AR101815A1 (en) COMPOUNDS AND COMPOSITIONS AS QUINASA INHIBITORS
PE20151606A1 (en) NAPHTHYRIDINE DERIVATIVES USEFUL AS ANTAGONISTS OF INTEGRINE AvB6
BR112017019286A2 (en) As anti-cancer drugs substituted 2-hydroperoxy-pyrazole derivative
AR100809A1 (en) 3-QUINASA PHOSFATIDYLINOSITOL INHIBITORS
AR088828A1 (en) CYCLHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC B2 AGONISTS AND AS M3 MUSCARINIC ANTAGONISTS
AR094299A1 (en) DERIVATIVES OF FTALAZIN-1 (2H) -ONA SUBSTITUTED
AR092347A1 (en) DERIVATIVES OF AZAINDOL
AR097079A1 (en) SALTS OF DERIVATIVES OF 2-AMINO-1-HYDROXYETYL-8-HYDROXYQUINOLIN-2 (1H) -ONE THAT HAVE ANTAGONIST ACTIVITY OF MUSCARINIC RECEPTORS AS WELL AS AGONIST ACTIVITY OF THE ADRENERICAL RECEIVER b2
CR20140294A (en) DERIVATIVES OF DIHIDRO-BENZO-OXAZINA AND DIHIDRO-PIRIDO-OXAZINA
AR100807A1 (en) 3-QUINASA PHOSFATIDYLINOSITOL INHIBITORS
AR090587A1 (en) TRICYCLE COMPOUNDS REPLACED WITH ACTIVITY TO THE EP1 RECEIVERS
AR094812A1 (en) DERIVED FROM MONOCYCLIC PYRIDINE AS AN FGFR INHIBITOR
CR20150419A (en) SUBSTITUTED DERIVATIVES OF PHOSPHONE BISPHENILE ACID AS INHIBITORS OF THE NEP
AR107321A1 (en) ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES
AR090557A1 (en) ADIDENIC AGONIST IMIDAZOLIC DERIVATIVES a2
AR106604A1 (en) CRYPTOFICINE COMPOUNDS AND CONJUGATED PRODUCTS, THEIR PREPARATION AND THERAPEUTIC USE
AR096153A1 (en) PIRROLO DERIVATIVES [2,3-D] PYRIMIDINE
AR101222A1 (en) DERIVATIVES OF PIRIDONA
PE20190803A1 (en) 1-ARYLNAFTIRIDIN-3-CARBOXAMIDES 7-SUBSTITUTED AND THEIR USE
AR091679A1 (en) POSITIVE ALLOSTERIC MODULAR NICOTINIC ACETILCOLINE RECEIVER
AR096424A1 (en) COMPOUNDS OF 3,4-DIHIDRO-2H-ISOQUINOLIN-1-ONA AND 2,3-DIHIDRO-ISOINDOL-1-ONA
AR113923A1 (en) IMIDAZOPYRIDINE DERIVATIVES AND THEIR USE AS A MEDICINAL PRODUCT

Legal Events

Date Code Title Description
FB Suspension of granting procedure